Evogene Ltd. ( EVGN) - Stock Earnings
EVGN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -5.3 million USD | 314000 USD |
| 2026Q1 | -5.9 million USD | 334000 USD |
| 2026Q2 | -1.8 million USD | 347000 USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
EVGN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -23.9 million USD | 3.0 million USD |
| 2024 | -16.5 million USD | 5.6 million USD |
| 2025 | -8.5 million USD | 3.9 million USD |
| 2026 Est. | — | — |
EVGN
Price: $0.48
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.75 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Israel
Volume: 71621
Ebitda: -8.5 millionMarket Capitalization: 4.6 million